{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:10:10Z","timestamp":1761588610380,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012116","name":"European Bioinformatics Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012116","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["202206090022"],"award-info":[{"award-number":["202206090022"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008868","name":"Jiangsu Provincial Department of Science and Technology","doi-asserted-by":"publisher","award":["BE2022821"],"award-info":[{"award-number":["BE2022821"]}],"id":[{"id":"10.13039\/501100008868","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.intimp.2023.110784","type":"journal-article","created":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T11:25:10Z","timestamp":1692530710000},"page":"110784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"PA","title":["Comprehensive analysis of m6A subtype classification for immune microenvironment of pituitary adenomas"],"prefix":"10.1016","volume":"124","author":[{"given":"Feng","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangming","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingshuai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaonan","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zixiang","family":"Cong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinrui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1710-5955","authenticated-orcid":false,"given":"Chiyuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2023.110784_b0005","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/jama.2016.19699","article-title":"Diagnosis and treatment of pituitary adenomas: A review","volume":"317","author":"Molitch","year":"2017","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.intimp.2023.110784_b0010","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrendo.2014.64","article-title":"Aggressive pituitary adenomas\u2013diagnosis and emerging treatments","volume":"10","author":"Di","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.intimp.2023.110784_b0015","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3171\/jns.2002.96.2.0195","article-title":"The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery","volume":"96","author":"Meij","year":"2002","journal-title":"J. Neurosurg."},{"issue":"1","key":"10.1016\/j.intimp.2023.110784_b0020","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","article-title":"Overview of the 2022 WHO classification of pituitary tumors","volume":"33","author":"Asa","year":"2022","journal-title":"Endocr. Pathol."},{"issue":"8","key":"10.1016\/j.intimp.2023.110784_b0025","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","article-title":"The history and advances in cancer immunotherapy: Understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications","volume":"17","author":"Zhang","year":"2020","journal-title":"Cell. Mol. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110784_b0030","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41576-022-00534-0","article-title":"Biological roles of adenine methylation in RNA","volume":"24","author":"Boulias","year":"2023","journal-title":"Nat. Rev. Genet."},{"issue":"13","key":"10.1016\/j.intimp.2023.110784_b0035","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1101\/gad.262766.115","article-title":"RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation","volume":"29","author":"Yue","year":"2015","journal-title":"Genes Dev."},{"issue":"3","key":"10.1016\/j.intimp.2023.110784_b0040","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.molcel.2023.01.006","article-title":"RNA m6A methylation across the transcriptome","volume":"83","author":"Sendinc","year":"2023","journal-title":"Mol. Cell"},{"issue":"3","key":"10.1016\/j.intimp.2023.110784_b0045","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s12276-023-00944-y","article-title":"The roles of N6-methyladenosine and its target regulatory noncoding RNAs in tumors: Classification, mechanisms, and potential therapeutic implications","volume":"55","author":"Liu","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.intimp.2023.110784_b0050","doi-asserted-by":"crossref","first-page":"679367","DOI":"10.3389\/fonc.2021.679367","article-title":"m6A Modification: A double-edged sword in tumor development","volume":"11","author":"Gao","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110784_b0055","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/s41467-020-15488-2","article-title":"METTL3 is essential for postnatal development of brown adipose tissue and energy expenditure in mice","volume":"11","author":"Wang","year":"2020","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.intimp.2023.110784_b0060","doi-asserted-by":"crossref","first-page":"e525","DOI":"10.1002\/ctm2.525","article-title":"RNA N(6) -methyladenosine modification in the lethal teamwork of cancer stem cells and the tumor immune microenvironment: Current landscape and therapeutic potential","volume":"11","author":"Zhang","year":"2021","journal-title":"Clin. Transl. Med."},{"issue":"13","key":"10.1016\/j.intimp.2023.110784_b0065","doi-asserted-by":"crossref","first-page":"e2106558","DOI":"10.1002\/smll.202106558","article-title":"Glutathione-bioimprinted nanoparticles targeting of N6-methyladenosine FTO demethylase as a strategy against leukemic stem cells","volume":"18","author":"Cao","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.intimp.2023.110784_b0070","doi-asserted-by":"crossref","first-page":"103271","DOI":"10.1016\/j.ebiom.2021.103271","article-title":"An integrated model of N6-methyladenosine regulators to predict tumor aggressiveness and immune evasion in pancreatic cancer","volume":"65","author":"Zhou","year":"2021","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.intimp.2023.110784_b0075","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12943-020-01170-0","article-title":"m(6)A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.intimp.2023.110784_b0080","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1210\/clinem\/dgab652","article-title":"METTL3-mediated RNA m6A hypermethylation promotes tumorigenesis and GH secretion of pituitary somatotroph adenomas","volume":"107","author":"Chang","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.intimp.2023.110784_b0085","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","article-title":"The sva package for removing batch effects and other unwanted variation in high-throughput experiments","volume":"28","author":"Leek","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.intimp.2023.110784_b0090","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2023.110784_b0095","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2023.110784_b0100","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.intimp.2023.110784_b0105","doi-asserted-by":"crossref","first-page":"7049294","DOI":"10.1155\/2019\/7049294","article-title":"Identification of key pathways and genes in the Orai2 mediated classical and mesenchymal subtype of glioblastoma by bioinformatic analyses","volume":"2019","author":"Yuan","year":"2019","journal-title":"Dis. Markers"},{"key":"10.1016\/j.intimp.2023.110784_b0110","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.intimp.2023.110784_b0115","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"PNAS"},{"key":"10.1016\/j.intimp.2023.110784_b0120","first-page":"12","article-title":"Logistic LASSO regression for dietary intakes and breast cancer","author":"McEligot","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.intimp.2023.110784_b0125","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","article-title":"How to build and interpret a nomogram for cancer prognosis","volume":"26","author":"Iasonos","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.intimp.2023.110784_b0130","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: An open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinf."},{"issue":"21","key":"10.1016\/j.intimp.2023.110784_b0135","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1200\/JCO.2015.65.5654","article-title":"Assessing the clinical impact of risk prediction models with decision curves: Guidance for correct interpretation and appropriate use","volume":"34","author":"Kerr","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.intimp.2023.110784_b0140","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s12022-015-9383-6","article-title":"Immune cell infiltrates in pituitary adenomas: More macrophages in larger adenomas and more T cells in growth hormone adenomas","volume":"26","author":"Lu","year":"2015","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.intimp.2023.110784_b0145","first-page":"8","article-title":"Analysis of tumor angiogenesis and immune microenvironment in non-functional pituitary endocrine tumors","author":"Sato","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.intimp.2023.110784_b0150","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11060-018-2844-2","article-title":"The expression profile of PD-L1 and CD8+ lymphocyte in pituitary adenomas indicating for immunotherapy","volume":"139","author":"Wang","year":"2018","journal-title":"J. Neurooncol"},{"key":"10.1016\/j.intimp.2023.110784_b0155","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1007\/s00262-020-02611-x","article-title":"Expression of programmed death-ligand 1 (PD-L1) in human pituitary neuroendocrine tumor","volume":"69","author":"Suteau","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.intimp.2023.110784_b0160","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1158\/1078-0432.CCR-18-3486","article-title":"Targeting PD-L1 initiates effective antitumor immunity in a murine model of cushing disease","volume":"26","author":"Kemeny","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2023.110784_b0165","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1210\/jc.2018-01347","article-title":"Marked response of a Hypermutated ACTH-secreting pituitary carcinoma to Ipilimumab and Nivolumab","volume":"103","author":"Lin","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.intimp.2023.110784_b0170","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/CAD.0000000000000856","article-title":"Rapid disease progression in patient with mismatch-repair deficiency pituitary ACTH-secreting adenoma treated with checkpoint inhibitor pembrolizumab","volume":"31","author":"Caccese","year":"2020","journal-title":"Anticancer Drugs"},{"issue":"5","key":"10.1016\/j.intimp.2023.110784_b0175","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41590-020-0650-4","article-title":"The RNA modification N6-methyladenosine as a novel regulator of the immune system","volume":"21","author":"Shulman","year":"2020","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110784_b0180","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/cr.2018.7","article-title":"m6A mRNA methylation sustains Treg suppressive functions","volume":"28","author":"Tong","year":"2018","journal-title":"Cell Res."},{"issue":"7743","key":"10.1016\/j.intimp.2023.110784_b0185","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-0916-x","article-title":"Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells","volume":"566","author":"Han","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.intimp.2023.110784_b0190","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40164-022-00269-y","article-title":"m(6)A binding protein YTHDF2 in cancer","volume":"11","author":"Chen","year":"2022","journal-title":"Exp. Hematol. Oncol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923011098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923011098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:05:16Z","timestamp":1761588316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923011098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":38,"alternative-id":["S1567576923011098"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110784","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive analysis of m6A subtype classification for immune microenvironment of pituitary adenomas","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110784","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110784"}}